2020

NervGen Pharma Corp. Completes $6.45 Million Public Offering

NervGen Pharma Corp. Announces Upsizing of Financing and Filing of Amended and Restated Prospectus Supplement

NervGen Pharma Corp. Announces Filing of Prospectus Supplement

NervGen Pharma Announces Pricing of Public Offering

NervGen Pharma Corp. Announces Public Offering

NervGen Pharma to Collaborate on Chronic Spinal Cord Injury Study Sponsored by the State of Ohio / Ohio Department of Higher Education Awards $250,000 Grant To Dr. Jerry Silver, Co-inventor of NervGen’s Lead Compound

NervGen Pharma Grants Stock Options

NervGen Pharma Reports First Quarter 2020 Results / Phase 1 Clinical Trial Remains on Track for Q4 2020

NervGen Pharma Corp. Closes Non-Brokered Private Placement